PMC5465688_01
Abdominopelvic CT shows an ulceroinfiltrating mass of 5 cm in size along the lesser curvature side of gastric antrum abutting the pancreas with perigastric infiltration with multiple lymphadenopathy in the perigastric area, the proper hepatic artery, and the common hepatic artery.
cro-0010-0217-g01.jpg
PMC5465688_01_cro-0010-0217-g01.jpg
f1
Abdominopelvic computed tomography (CT) showed a 5-cm-sized ulceroinfiltrating mass along the lesser curvature side of the gastric antrum abutting the pancreas with perigastric infiltration with multiple lymphadenopathy (Fig. 1).
The 18F-FDG PET/CT scan shows advanced gastric cancer located at the prepyloric antrum and hypermetabolic lymphadenopathy at metastatic lymph nodes in the prepyloric and pancreatoduodenal area.
cro-0010-0217-g02.jpg
PMC5465688_01_cro-0010-0217-g02.jpg
f2
Fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET/CT) showed advanced gastric cancer located at the prepyloric antrum and hypermetabolic lymphadenopathy at the metastatic lymph nodes in the prepyloric and pancreatoduodenal area (Fig. 2).
Follow-up EGD 8 years after operation shows no evidence of cancer recurrence.
cro-0010-0217-g03.jpg
PMC5465688_01_cro-0010-0217-g03.jpg
f3
EGD and CT every 6 months after the operation were conducted. EGD (Fig. 3), abdominopelvic CT (Fig. 4), and PET/CT (Fig. 5) performed 96 months after the operation revealed no evidence of cancer.
Follow-up 18F-FDG PET/CT 8 years after operation shows no evidence of cancer recurrence.
cro-0010-0217-g05.jpg
PMC5465688_01_cro-0010-0217-g05.jpg
f5
EGD and CT every 6 months after the operation were conducted. EGD (Fig. 3), abdominopelvic CT (Fig. 4), and PET/CT (Fig. 5) performed 96 months after the operation revealed no evidence of cancer.